Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Staphylococcus aureus response and adaptation to vancomycin.

Advances in microbial physiology - 1 Jan 2024

Fait Anaëlle, Silva Stephanie Fulaz, Abrahamsson Jack Åke Harry, Ingmer Hanne

Abstract excerpt

Antibiotic resistance is an increasing challenge for the human pathogen Staphylococcus aureus. Methicillin-resistant S. aureus (MRSA) clones have spread globally, and a growing number display decreased susceptibility to vancomycin, the favoured antibiotic for treatment of MRSA infections. These vancomycin-intermediate S. aureus (VISA) or heterogeneous vancomycin-intermediate S. aureus (hVISA) strains arise from...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adaptation, Physiological
Share to Gene Expression Regulation, Bacterial

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Methicillin-Resistant Staphylococcus aureus

Share to Microbial Sensitivity Tests

Share to Staphylococcal Infections

Share to Staphylococcus aureus

Share to Vancomycin

Share to Vancomycin Resistance

Source

Identifiers

PMID: 39059821
DOI: 10.1016/bs.ampbs.2024.04.006

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Staphylococcus aureus response and adaptation to vancomycin.PMID 39059821Read ↗

The evolution of vancomycin intermediate Staphylococcus aureus (VISA) and heterogenous-VISA.Semantic proximity Read ↗

Molecular Events for Promotion of Vancomycin Resistance in Vancomycin Intermediate Staphylococcus aureusSemantic proximity Read ↗

Comprehensive identification of mutations responsible for heterogeneous vancomycin-intermediate Staphylococcus aureus (hVISA)-to-VISA conversion in laboratory-generated VISA strains derived from hVISA clinical strain Mu3.Semantic proximity Read ↗

Reduced Vancomycin Susceptibility in <i>Staphylococcus aureus</i> , Including Vancomycin-Intermediate and Heterogeneous Vancomycin-Intermediate Strains: Resistance Mechanisms, Laboratory Detection, and Clinical ImplicationsSemantic proximity Read ↗

Mechanisms of vancomycin resistance in Staphylococcus aureus.Semantic proximity Read ↗

A novel mutation of walK confers vancomycin-intermediate resistance in methicillin-susceptible Staphylococcus aureus.Semantic proximity Read ↗

The escalating challenge of vancomycin resistance in Staphylococcus aureus.Semantic proximity Read ↗

Insights into the molecular basis of reduced vancomycin susceptibility among three prominent Staphylococcus aureus clonal complexesSemantic proximity Read ↗

Single-nucleotide polymorphisms in a vancomycin-resistant Staphylococcus aureus strain based on whole-genome sequencing.Semantic proximity Read ↗

"Slow VISA," a novel phenotype of vancomycin resistance, found in vitro in heterogeneous vancomycin-intermediate Staphylococcus aureus strain Mu3.Semantic proximity Read ↗

Environmental conditions dictate differential evolution of vancomycin resistance in Staphylococcus aureus.Semantic proximity Read ↗

Genomic and phenotypic adaptations of methicillin resistant Staphylococcus aureus during vancomycin therapySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.